BioNTech Sues Moderna for Patent Infringement Over COVID Shots

Share!

Insurance Journal - Feb 20, 2026

German biopharmaceutical company BioNTech sued Moderna in Delaware federal court on Thursday, alleging that Moderna’s COVID-19 vaccine mNEXSPIKE infringes a patent related to BioNTech and Pfizer’s competing shot Comirnaty. The lawsuit said that mNEXSPIKE, Moderna’s next-generation...

Read Full Article

Recommended Articles

Texas Summer Camp Faces Scrutiny Over Failure to Report Deaths

Posted: Apr 16, 2026

The medical officer for the Texas summer camp where 27 girls were killed in a flood last year testif...

Trucordia Buys Connecticut’s Paradiso Insurance Services

Posted: Apr 16, 2026

Utah-based insurance broker Trucordia reports it has acquired the Paradiso Financial and Insurance S...

Inszone Acquires Kansas’ Insurance Resources Group

Posted: Apr 16, 2026

Inszone Insurance Services announced the acquisition of Insurance Resources Group, Inc. Located in O...